pregnancy management	
evaluations can include:	
evaluations include:	
mothertobaby	
evaluations can include the following:	
use of antiepileptic medication during pregnancy reduces this risk	
search clinicaltrials	
see mothertobaby for further information on medication use during pregnancy	
org	C1522486//Professional Organization or Group//MTH
therapies under investigation	
other	C0205394//Other//MTH	C0220886//Other location of complaint//MTH	C1271040//Other health professional//MTH	C1521979//Other Route of Drug Administration//MTH	C1546380//Other - Event Reason//MTH	C1546725//Other Specimen Source Code//MTH	C1546836//Other - Special Program Code//MTH	C1546840//Other - Publicity Code//MTH	C1546902//Other - Diagnosis Classification//MTH	C1546930//Other - Report Source//MTH	C1547110//Other - Modality//MTH	C1547196//Other - Organization unit type//MTH	C1547233//Other - Triage Code//MTH	C1547241//Other - Newborn Code//MTH	C1547267//Other - Risk Management Incident Code//MTH	C1547272//Other - Incident Type Code//MTH	C1547281//Other - Production Class Code//MTH	C1547292//Other - Recreational Drug Use Code//MTH	C1547304//Other - Precaution Code//MTH	C1547309//Other - Patient Condition Code//MTH	C1547994//Other - Diagnostic Service Section ID//MTH	C1549063//Other - Notify Clergy Code//MTH	C1549104//Other - Administrative Gender//MTH	C1549110//Other - Marital Status//MTH	C1550146//Other - Substance Type//MTH	C1556042//Other - Relationship//MTH	C1556043//Other - Religion//MTH	C1556044//other - No Information//MTH	C1556045//Other - What subject filter//MTH	C1556046//Other - Employment Status//MTH	C1556048//Other - Contact Role//MTH	C1556049//Other - Mail Claim Party//MTH	C1556050//Other - Living Dependency//MTH	C1556051//Other - Event Consequence//MTH	C1556052//Other - Indirect exposure mechanism//MTH	C1556053//Other - Action Taken in Response to the Event//MTH	C1556054//Other - Status of Evaluation//MTH	C1556055//Other - Causality Observations//MTH	C1556056//Other - Job Status//MTH	C1556057//Other - Immunization Registry Status//MTH	C1561608//Other - Mode of Arrival//MTH	C1868670//Other Growth//MTH	C1996846//Other (qualifier in LNC)//MTH	C2598149//Other:-:Point in time:^Patient:-//MTH	C3496095//Other - HRSA Program//MTH	C3889261//Other License Status//MTH	C4050255//Other Establishment Activity//MTH
males	C0086582//Males//MTH
females	C0086287//Females//MTH
molecular genetic testing	
identification of at-risk relatives	
early determination of the genetic status of males at risk	
determination of genetic status of females at risk	
obstetric issues	
newborn males	
cys282tyr	
particularly important are:	
240 (170)	
a parent, sib, or child	
first-degree relatives share about half of their genes	
a first cousin, great-grandparent, or great-grandchild	
during pregnancy	
see www	
monitoring for these possible complications is recommended	
the characteristic urinary steroid profile:	
significantly elevated metabolites associated with:	
fertility may be a concern	
no reports describe reproduction in individuals with pord	
hepatic drug metabolism	
the common pathogenic variant p	
stress should be minimized by providing good analgesia	
urinalysis	C0042014//Urinalysis//MTH
a single urinalysis is sufficient in a male	
relatives who have the family-specific pathogenic variant should:	
undergo alps-specific evaluations at initial diagnosis (e	
, lymphoma) become apparent (see surveillance)	
severe dyslipidemia	
and hyperglycemia	
intensive multidisciplinary surveillance of any pregnancy would be mandatory	
leu167del variant	
if the apoe p	
a woman with the apoe p	
they are usually identified during family screening	
plasma quantitative amino acid analysis	
analysis of enzymatic activity in red blood cells	
all pregnancies had a good outcome	
peripartum intensive monitoring is advised	
medication-associated risks to the fetus	
, a beta-blocker) prior to conception	
ecg, with consideration of signal-averaged electrocardiogram	
echocardiogram	C0013516//Echocardiography//MTH	C2243117//Echocardiogram (image)//MTH
holter monitoring	C0013801//Holter Electrocardiography//MTH
cardiac mri	C0412692//Magnetic Resonance Imaging (MRI) of Heart//MTH
however, prenatal physiotherapy may be indicated	
affected women should continue biotin and thiamine therapy during pregnancy	
an optimal prenatal dose has not been determined	
pregnancy may increase the risk of diabetic decompensation	
for an affected mother	
no pregnancy manaagement issues are known	
for an affected child	
no special management is required during pregnancy	
pregnant females with classic 21-ohd cah	
polyhydramnios	C0020224//Polyhydramnios//MTH
the cause of polyhydramnios is unknown	
macrosomia	C0158915//Exceptionally large baby (disorder)//MTH	C1848395//Large for gestational age//MTH
molecular genetic testing for the causative contiguous gene deletion	
otologic examination and audiologic assessment	
0 mg im, folic acid 5	
of the 16 women, hemorrhage occured in ten	
6% compared with 1	
see malignant hyperthermia susceptibility for more details	
deterioration during pregnancy may precipitate preterm delivery	
mode of delivery is based on usual obstetric indications	
data regarding teratogenicity of itraconazole are limited	
the infants were normal	
early diagnosis of relatives (i	
completely asymptomatic individuals need not be tested	
no issues are known	
however, experience is limited	
females with ciss may conceive normally	
no complications during pregnancy have been reported to date	
the prescription of clonidine should not be discontinued abruptly	
data on pregnancies in cms are limited	
trpv4-associated neuromuscular disorders	
trpv4-associated skeletal dysplasias	
no specific pregnancy management recommendations have been published	
the symptoms of cmt can worsen during pregnancy	
in particular: cramps, subjective sensitivity (e	
, paresthesias), difficulty walking, and fatigue	
no obvious effect has been observed	
acute fatty liver of pregnancy	C1455728//Acute fatty liver of pregnancy//MTH
maternal liver disease	
it is appropriate to evaluate relatives at risk (e	
treatment with chenodeoxycholic acid should not be interrupted during pregnancy	
otherwise serial ancs can be evaluated	
other findings included:	
dose adjustment may also be required post partum	
pregnancy management for heterozygous females	
, coronary artery disease)	
, left ventricular enlargement but normal function	
in most cases, pregnancy is contraindicated in dcm	
evaluations may include:	
consideration of other testing (e	
during pregnancy the maternal hemoglobin level must be monitored	
intrauterine growth retardation	C0015934//Fetal Growth Retardation//MTH
preeclampsia	C0032914//Pre-Eclampsia//MTH
retroplacental hematoma	C0473391//Retroplacental hematoma//MTH
in utero fetal death	
preterm delivery	C0151526//Premature Birth//MTH
telomere length testing	
they should be followed closely by a perinatologist	
recommendations vary by underlying genetic mechanism:	
two women reported mild deterioration of dystonia	
an increase in dose was required in one	
see mothertobaby	
org for further information on medication use during pregnancy	
2-q13	
caesarean section delivery may be required	
labor and delivery may progress very rapidly	
there is no clear advantage to vaginal vs	
cesarean delivery	C0007876//Cesarean section//MTH	C1384674//Cesarean section (finding)//MTH
delivery should be performed in a medical center	
pregnancy is not complicated by epp	
there is no information on pregnancy management in xlp	
measure α-gal a enzyme activity	
however, the indications for family testing are unresolved	
recommended genetic testing for at-risk family members	
pregnancy/fertility/hormone use	
visceral pain related to contractions during labor is perceived normally	
therefor, analgesia should be provided	
this is especially important when the p	
poncz & cohen 1996	
min et al 2008	
goldman, personal communication to author]	
diagnostic evaluations can include:	
molecular genetic testing for the familial gata1 pathogenic variant	
effect of anticonvulsants on hormonal methods of birth control	
effects of anticonvulsants on conception	
effect of pregnancy on anticonvulsant metabolism	
effect of pregnancy on maternal seizure control	
renal anomalies	C0266292//Congenital anomaly of the kidney//SNOMEDCT_US
skeletal differences such as club foot and craniosynostosis	
and umbilical and inguinal hernia	
baseline ultrasound of liver and kidneys prior to pregnancy	
consideration of referral to high-risk obstetrician	
metabolic control should be followed closely throughout the pregnancy	
abdominal ultrasound should be performed every six to 12 weeks	
the effect of pregnancy on inducing acute attacks is unpredictable	
in general, serious problems during pregnancy are unusual	
if the female is symptomatic (i	
range: 15%-50%)	
the following strategy is appropriate:	
perform iron studies (i	
no guidelines exist	
common practice is to withhold phlebotomy during pregnancy	
coli sepsis and pulmonary edema	
testing of populations at risk	
cessation of prophylactic antimicrobials is often advised during pregnancy	
ideally cancer screening exams would be planned around a pregnancy	
hyperpyrexia and its potential complications, including febrile seizures	
, first 28 days of life)	
no monitoring is needed for:	
8%) and preeclampsia (7	
7%)	
children because of their increased risk for anemia	
measurement of ldl-c level	
table 4	
degree of relatedness to an affected individual	
first degree 1	
second degree 2	
third degree 3	
cholesterol levels	C0201950//Cholesterol measurement test//MTH	C0428466//Cholesterol level test result//MTH
total cholesterol (ldl cholesterol) in mg/dl	
age	C0001779//Age//MTH	C0162574//Glycation End Products, Advanced//MSH	C1114365//Age:Time:Point in time:^Patient:Quantitative//MTH
<20	
220 (155)	
230 (165)	
20-29	C3844816//20-29//LNC
250 (180)	
260 (185)	
30-39	C3844815//30-39//LNC
270 (190)	
280 (200)	
290 (210)	
40+	
290 (205)	
300 (215)	
310 (225)	
statins are contraindicated during pregnancy	
pharmacologic treatment	
statins are contraindicated in pregnancy due to concerns for teratogenicity	
nursing mothers should not take statins	
ldl apheresis is also occasionally used	
regarding other agents:	
pcsk9 inhibitors	C4051516//PCSK9 Inhibitors [MoA]//NDFRT
use during pregnancy has not been well studied	
ezetimibe	C1142985//ezetimibe//MTH
use during human pregnancy has not been well studied	
niacin	C0027996//Niacin//MTH	C1142562//Vitamin B3 Assay//MTH
higher doses have been associated with toxicity	
risks during delivery include cephalopelvic disproportion	
pregnancy in women with parkinson disease is a rare event	
see hereditary hemorrhagic telangiectasia, pregnancy management	
see mothertobaby for more information on medication use during pregnancy	
edema may be exacerbated during pregnancy	
if the ptpn11, raf1,	
some carrier females develop gout in later years	
if the causal tgfbr1,	
pregnancy can be dangerous for women with lds	
it is appropriate to evaluate at-risk sibs during infancy	
measurement of plasma triglyceride concentration	
affected mother	
affected fetus	
0 cm	
at a root dimension <5	
0cm) before becoming pregnant	
pregnant women who have mcad deficiency must avoid catabolism	
for the purpose of early diagnosis and treatment	
for the purpose of kidney donation	
no pregnancy issues are particular to adtkd-umod	
thus, no particular recommendations can be made	
no prenatal or perinatal neurologic manifestations of mls are known	
using genomic testing that will detect the 15q13	
close monitoring for intrauterine growth retardation is warranted	
using genomic testing that will detect the 1q21	
3 microdeletion	
infertility may preclude pregnancy in some affected individuals	
men 2a	C0025268//Multiple Endocrine Neoplasia Type 2a//MTH
fmtc	C1833921//Familial medullary thyroid carcinoma//MTH
men 2b	C0025269//Multiple Endocrine Neoplasia Type 2b//MTH
albumin-corrected calcium or ionized calcium for hyperparathyroidism	
, cardiac and renal defects)	
fetal monitoring should follow standard guidelines	
continuous epidural analgesia is highly recommended for labor and delivery	
therapies under investigations	
ultrasound abnormalities are not present in all affected pregnancies	
abnormal presentation of an affected fetus may complicate delivery	
no information on pregnancy management and outcomes is available	
penetrance rates, however, are not known	
the post-partum period is dangerous for the mother	
evaluation includes targeted molecular genetic testing for the fgfr3 c	
749c>g pathogenic variant	
evaluation for placenta previa	
otherwise, monitor renal findings (i	
additional testing is not indicated	
the first pregnancy ended in miscarriage at 19 weeks	
, pre-eclampsia)	
no treatment for the condition is available	
birth is usually normal and uncomplicated	
fetal akinesia often causes congenital contractures	
clonus persists after birth and is usually severe	
absence of respiratory movement necessitates mechanical support at birth	
if not, treatment can be withdrawn	
, avoidance of unattended swimming)	
see treatment of manifestations	
possible those who would benefit from initiation of treatment	
1994a, schwartz et al 1994b]	
it is recommended that every five years, asymptomatic	
standardized questionnaire to assess the presence of respiratory	
symptoms	C0683368//Symptoms aspect//MTH	C1457887//Symptoms//MTH
family members are considered to have a positive screening	
evaluation (i	
, to possibly have pulmonary fibrosis) if they	
family members	C0086282//Family member//MTH
radiologic and histopathologic abnormalities suggestive of possible	
early interstitial lung disease	
it is unknown if these findings would	
become symptomatic fpf in the subjects	
see genetic	
genetic counseling purposes	
if the epor pathogenic variant in the family is known	
if no pathogenic variant has been identified in the family	
asymptomatic individuals:	
can be monitored periodically for renal function and urinary oxalate	
should maintain adequate hydration and avoid high-oxalate foods	
in addition:	
for those with the pathogenic variant p	
gly170arg or p	
phe152ile, pyridoxine should be supplemented	
, heterozygous for one hoga1 pathogenic variant)	
adequate fluid intake should be maintained throughout the pregnancy	
measurement of serum potassium concentration and blood pressure	
early diagnosis and treatment	
surveillance as outlined in surveillance	
see related genetic counseling issues	
presymptomatic diagnosis:	
permits early detection and treatment of complications and associated disorders	
reassures those found to be unaffected	
the literature on pregnancy and pkd is limited	
women with pah deficiency	
preconception	C2982736//Preconception//NCI
assessment of early osteopenia risk	
discontinuation of lnaa treatment	
post partum	C0086839//Postpartum Period//MTH
provide coordinated care in the post-partum period	
spasticity generally does not change significantly with pregnancy	
pregnancy is generally not complicated by f-pct	
newer effective therapies may decrease the risk	
and an audiology evaluation	
see published guidelines/consensus statements	
prophylactic anticoagulation during pregnancy:	
is recommended for all women:	
should be considered for:	
all women received a course of postpartum anticoagulation	
all asymptomatic homozygous women	
prevention of pregnancy loss	
trialregister	
nl, ntr 3361)	
studies suggesting that prophylactic anticoagulation improves pregnancy outcome:	
5% and 15	
other pregnancy complications	
young or uncooperative children may require examination under anesthesia	
recommended doses during pregnancy are 10 mg/kg/day	
evaluation can be accomplished by:	
pregnancy in affected women appears to be generally uncomplicated	
that has documented lqts	
in which evaluation for lqts has not been performed	
or both of the following:	
weight gain during pregnancy can further impair gait ataxia	
affected women may be on medications (e	
, antiepileptics) to control the symptoms of sca17	
successful pregnancies have occurred in women with short syndrome	
if present, diabetes mellitus is managed as appropriate	
the following are appropriate:	
clinical appraisal and lateral skull radiograph as indicated	
no pregnancy complications have been reported	
almost all develop thrombocytopenia during pregnancy	
it can be addressed on three levels:	
maternal	C0026591//Mother (person)//MTH	C0036379//Schools, Nursery//MTH	C1858460//Maternal//MTH	C2347083//Maternal Relative//MTH
avoidance of emergency c-section for fetal distress	
fetal	C0015965//Fetus//MTH	C0033052//Prenatal care//MTH	C0521457//Fetal//MTH
familial	C0015576//Family//MTH	C0241888//Familial//MTH
org for more information on medication exposure during pregnancy	
audiology	C0004285//Audiology//MTH	C1547975//Audiology Section ID//MTH
abr, dpoae	
such test results need to be interpreted with caution	
, vhl syndrome or other hereditary disorder)	
during pregnancy, affected women may develop small new lesions	
penetrance is complete (i	
delayed, secondary postpartum bleeding may be a problem	
wolfram syndrome	C0043207//Wolfram Syndrome//MTH
low-frequency sensorineural hearing loss (lfsnhl)	
pregnancies in women with ws are high risk	
zinc has been used effectively during pregnancy	
org for more information on medication use during pregnancy	
there are no other special recommendations for pregnancy management	
regular monitoring with pregnancy tests is indicated	
